SciELO - Scientific Electronic Library Online

 
vol.30 issue3Validation of phone messages to promote health in people with HIVAssociation between intensities of pain and sedation in intensive care patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Acta Paulista de Enfermagem

On-line version ISSN 1982-0194

Acta paul. enferm. vol.30 no.3 São Paulo May/Jun. 2017

http://dx.doi.org/10.1590/1982-0194201700036 

Original Articles

Effect of Astrocaryum aculeatum (tucumã) on doxorubicin toxicity: in vivo experimental model

Alan Bruno Aurélio Carneiro1 

Eduardo Júnior Serrão Pinto1 

Ivagner Ferreira Ribeiro1 

Mayck Rian Gonçalves Magalhães2 

Moacir de Azevedo Bentes Monteiro Neto1 

1Universidade Federal do Amapá, Macapá, AP, Brazil.

2Faculdade Estácio de Macapá, Macapá, AP, Brazil.

Abstract

Objective

To obtain the oil of Astrocaryum aculeatum (A.a), and evaluate its genotoxicity/antigenotoxicity activities using the micronucleus test in peripheral blood cells.

Methods

The oil of Astrocaryum aculeatum was obtained by hydraulic pressing. The animals used were healthy Swiss male mice, at 6-7 weeks of age; there were six per group. The genotoxic and antigenotoxic activity of concentrations were 500, 1,000 and 2,000 mg/kg per 0.5 mL (oral), followed or not followed by intraperitoneal injection of doxorubicin (0.3 mL-15 mg/kg by body weight), in addition to a negative group (water) and dimethyl sulfoxide (600 μL). Peripheral blood samples were collected 24h and 48h after treatment.

Results

A statistically significant reduction was identified in the frequency of micronuclei in polychromatic cells ranging from 34.72% to 38.19% for 24-hour treatments, and from 63.70% to 66.12% for 48 hour.

Conclusion

The fixed oil of tucumã presented antigenotoxic potential for the concentrations used in acute treatments.

Key words: Doxorubicin/toxicity; Plant extracts/analysis; Micronucleus tests

Introduction

The Astrocaryum aculeatum (tucumã) is a fruit of yellow color with reddish tones, which is from a palm tree of the Arecaceae Family that reaches 10 to 25 meters high, 15 to 30cm in diameter,1usually solitary, stem with dark thorns, ascending leaves, erect flowers and broadly distributed in Amazon, which presents great biodiversity of the genus Astrocaryum.1,2 This is an exceptionally tolerant species to acidic and nutrient poor soils, which is characteristic of the Amazonian region.3

The fruit has an ovoid shape, whose fibrous mesocarp provides a high nutritional content. The pulp is well appreciated, and consumed in natura by the population, or as a filling in sandwiches, tapiocas, custard, ice cream, and flour.4

de Rosso & Mercadante5 described 24 carotenoids; 21 were chemically identified in the tucumã. Tucumã analysis show one of the highest concentrations of pro-vitamin A, representing 52 mg/100 g of pulp, with a potential antioxidant that block the harmful effects caused by free radicals. Carotenoids are essential for cell differentiation, embryonic development, vision, as well as many other functions, including potential therapeutic benefits5,6

According to Ambrósio et al., (2006),7 β-carotene is a powerful antioxidant that protects against cardiovascular diseases by inhibiting the oxidative process of low-density lipoprotein (LDL). Important polyphenols, such as quercetin, are also present in tucumã, which is one of the main flavonoids present in the human diet. Flavonoids are compounds found in plants, which also have antioxidant properties.7,8

Chemotherapeutic doxorubicin (DXR) is an anthracyclic antibiotic and a potent, broad spectrum, antitumor medicine, frequently used in combination with different medicines in the treatment of acute leukemia, lymphomas and solid tumors, such as breast, ovarian, and endometrial. Its toxicity can be caused in different ways: its planar agglutinated portion can be inserted between adjacent base pairs in the DNA, modifying the ability of nuclear helicases to dissociate the DNA double-strand and the topoisomerase II enzyme. Acting as an aggressor for this enzyme, it modifies its normal purpose to induce DNA damage, which occurs by loss of one or two electrons, generating reactive compounds with the potential to damage macromolecules and lipid membranes.9

Chemotherapy is a method that uses chemical compounds for treatment of diseases by biological agents, called chemotherapeutic. When used for cancer, it is called antineoplastic chemotherapy, and according to the Federal Nursing Council, the nurse is the one who can administer these medications. The nurse must know that there are natural ways to assist with this treatment,10 in which the oil of tucumã presents with considerable potential for the support of chemotherapy, as vitamin A produces less side effects, and prevents a break in the continuity of treatment. The present study may provide a theoretical basis to support advanced nursing practice in cancer patients.11

The consumption of fruits rich in antioxidants prevents excessive oxidation by the body itself, or in actions of medications such as doxorubicin, which promotes the production of free radicals that, if not controlled, can cause cellular damage which may lead to the development of several chronic and degenerative diseases.9 As the search for natural antioxidants has increased greatly in recent years, mainly for applications in the pharmaceutical, cosmetic and nutritional sectors, the hypothesis for this study is that the consumption of tucumã should be encouraged.

The objective of this study is to obtain the oil of Astrocaryum aculeatum (A.a) (tucumã) and to evaluate the genotoxicity/antigenotoxicity using the micronucleus test in peripheral blood cells.

Methods

Obtaining the fixed oil from Astrocaryum aculeatum

The oil was supplied by the Institute of Scientific and Technological Research of the State of Amapá (IEPA). The fruit was washed dry and the seed was removed to obtain the mesocarp, which was distributed onto trays for dehydration in a greenhouse, with air recirculation at 50°C for 24 hours, and then was cooled to room temperature.

The resulting mass was quantified at 28.21% of the total initial mass. The dry material was subjected to hydraulic pressing, with 15 tons capacity (SIWA model FM3), obtaining 22.21% of fixed oil.

Chemical agent inducing DNA damage

The chemotherapeutic agent, doxorubicin (DXR, Rubidox®), was used as a micronucleus inducer in peripheral blood cells, as a positive control. The chemical inducer was dissolved in distilled water and intraperitoneally administered (0.3 mL/animal) at the concentration of 15 mg/kg body weight, established according to studies of Franke et al.,12and Venkatesh et al.13

Animals and Treatments

Swiss male mice were used for the experiments; they were 6-7 weeks of life, with a body weight of approximately 30g; they were obtained from the Biothermium of the Multidisciplinary Center for Biological Research in the Laboratory Animal Science Area (CEMIB) of the University of Campinas (UNICAMP). The research was conducted in accordance with international protocols, regarding the use and care of laboratory animals. The animals were kept in grid boxes with dimensions of 30x19x12cm in a experimental room, under the following controlled conditions: temperature (22±2°C), humidity (50±10%), 12 hours of light-dark cycle, with ad libitum access to feed and water. The treatment protocols performed in this study were approved by the Committee of Ethics in the Use of Animals of UNIFAP, protocol 0012/2015.

Experimental design

The animals were divided into different groups, with six mice in each treatment group. The concentrations of the fixed oil of Astrocaryum aculeatum (A.a) were 500, 1,000 and 2,000 mg/kg of body weight, administered by gavage (0.5 ml) for observation of the genotoxic processes. The oil dilutions were made, respectively, in 0.5 ml of distilled water, with the solvent dimethylsulfoxide (DMSO) in the concentrations 150μl, 300μl and 600μl, respectively.

For antigenotoxic evaluation, immediately after administration of the A. a, the animals were treated with an intraperitoneal injection of DXR (0.3 ml), at a dose of 15 mg/kg of corporal weight. The solvent group is represented by treatment with DMSO at the concentration of 600 μl, because it was the dosage used in animals receiving 2,000 mg/kg of body weight of A.a. Peripheral blood samples from the acute treatment groups were collected after 24 and 48 hours (Table 1).

Table 1 Experimental groups and acute treatment protocols for the micronucleus test 

Treatment Group Dosage (mg/kg)
Negative control 1a,b -
DMSO 2a -
A. a I 3a 500
A. a II 4a 1,000
A. a III 5a 2,000
DXR 6a,b 15
DMSO + DXR 7b As in (2) and (6)
A. a. I + DXR 8b As in (3) and (6)
A. a II + DXR 9b As in (4) and (6)
A. a III + DXR 10b As in (5) and (6)

DMSO - Dimethyl sulfoxide; A. a. - Astrocaryum aculeatum; DXR - Doxorubicin; a protocols for genotoxicity; b protocols for antigenotoxicity

Micronucleus test

The levels of micronucleated polychromatic erythrocytes (MNPCEs) in the peripheral blood were sampled based on the technique of MacGregor et al.,14 and adapted, consisting of the following procedures:

  • The tip of the animals’ tails were cut and blood was dripped directly onto the dry slides;

  • The material was smeared with a cover slip;

  • The material was fixed in methanol for five minutes, after drying;

  • The material was stained with Giemsa in the next day, according to the Manual for the Laboratory Diagnostic of Malaria (2005). Giemsa powder 0.75g was used for each 100 ml of the solution - 35 ml Glycerol and 65 ml Methanol, in a ratio of 1:10 (Giemsa/buffered water), for 20 minutes.

  • Less mature micronuclei in polychromatic erythrocytes (PCEs) that were stained in blue were analyzed. More mature Nitrous Erythrocytes (NCEs) showed little or no influence from the stain, and were not analyzed.

Analysis of the glass slides

The glass slides of each animal were coded and analyzed within a short time in a blind test, in order to eliminate analysis errors. The analysis was performed by three observers, using a balanced system; that is, an equal number of cells were analyzed on different glass slides, for each animal of the study, by each observer.

The glass slides were first analyzed under a 40x mean magnification optical microscope to find fields of good technical quality, where the cells were well spread, undamaged and properly stained. After these fields were located, the observers followed the cell analysis process to identify the presence of the micronucleus, using a 100x magnification (immersion lens).

The micronucleus distribution among the cells may have value in identification of the mechanism, so, for its determination, 2,000 PCEs per animal were analyzed in the peripheral blood samples (24h and 48h), and a total of 400 erythrocytes per animal were analyzed to calculate the Nuclear Division Index (IDN)15-17 using the formula:

IDN=PCEPCE+NCE

The percentage of frequency reduction of PCEMNs was calculated according to Waters et al. (1990),18 to determine the effectiveness of treatments for antigenotoxic effect, using the following formula:

% of reduction=A-BA-C

A corresponds to the DXR group (positive control), B corresponds to the groups treated with A. a. + DXR (antigenotoxic groups), and C corresponds to the group treated with water (negative control).

Statistical analysis

The data were analyzed statistically using the analysis of variance (ANOVA) for completely randomized experiments, with the calculation of the F statistic and respective “p-values”. In cases where p <0.05, the treatment means were compared using the Tukey method, with the calculation of the minimum significant difference for α = 0.05, using the Graph Pad Prism 6 program.

Results

The results obtained for the treatments in Swiss mice with different doses of the fixed oil of Astrocaryum aculeatum, and/or these combined with the intraperitoneal administration of DXR in the dosage of 15 mg/kg of body weight, and their respective controls are shown in table 2.

Table 2 Frequencies of micronucleated polychromatic erythrocytes (PCEMNs) from the peripheral blood cells of animals submitted to treatment of different doses of A.a., and their respective controls 

Treatment (mg/kg of body weight) PCEMNs total PCEMNs (mean ± SD)
24 h 48 h 24 h 48 h
Control 27 26 4.50 ± 0.55 4.33 ± 0.52
DMSO 31 34 5.16 ± 0.63 5.66 ± 0.82
A. a. I (500 mg) 29 29 5.16 ± 0.98 4.83 ± 0.41
A. a. II (1000 mg) 29 29 4.83 ± 0.75 4.83 ± 0.75
A. a. III (2000 mg) 28 28 4.66 ± 0.52 4.66 ± 0.52
DXR mg 171ª 274ª 28.50 ± 1.38 45.66 ± 1.63
DMSO + DXR 167ª 267ª 27.83 ± 0.75 44.66 ± 1.05
A. a. I + DXR 121ª,b 116ª,b 20.16 ± 1.16 19.33 ± 0.52
A. a. II + DXR 118ª,b 111ª,b 19.66 ± 1.03 18.50 ± 0.55
A. a. III + DXR 116ª,b 110ª,b 19.33 ± 1.37 18.33 ± 0.52

A total of 2,000 PCEs were analyzed per animal, for a total of 12,000 cells per treatment; DXR: doxorubicin (15mg/kg body weight); ªsignificant difference for control group (p<0.05); b Significant difference for the DXR group (p < 0.05).

Simultaneous administration of a single oral dose of each fixed oil concentration of Astrocaryum aculeatum per gavage and intraperitoneal injection of DXR, resulted in a significant reduction in the frequency of PCEMNs. Values ranging from 34.72% to 38.19% for the 24-hour treatments (Figure 1), and from 63.70 to 66.12% for the 48-hour treatments where found (Figure 2), when compared to the group treated with DXR alone. The gradual increase of the fixed oil concentration of Astrocaryum aculeatum resulted in a proportional increase in the reduction of genotoxicity in 24 hours; however the evaluation of the treatments at 48 hours indicated no dose-response relationship (Table 2). The frequency of PCEMNs was lower in animals treated with DMSO + DXR than in those treated with DXR alone, but these differences were not statistically significant, and the IDN did not show any indication of cytotoxic potential in all groups evaluated (Table 3).

Figure 1 Frequencies of PCEMNs after 24 hours of treatment, with different doses of A.a. and DXR, and their respective controls 

Figure 2 Frequencies of PCEMNs after 48 hours of treatment, with different doses of A.a. and DXR, and their respective controls 

Table 3 Results of A.a. and DXR treatments and their respective controls (at 24 and 48 hours) 

Treatment (mg/kg body weight) IDN PCEMNs/1,000 PCEs REDUCTION (%)
24 h 48 h 24 h 48 h 24 h 48 h
Control 0.011 ± 0.51 0.010 ± 0.51 2.25 2.16 - -
DMSO 0.013 ± 0.54 0.011 ± 0.54 2.58 2.83 - -
A. a. I 0.013 ± 0.54 0.011 ± 0.83 2.42 2.42 - -
A. a. II 0.014 ± 0.75 0.013 ± 0.75 2.42 2.42 - -
A. a. III 0.013 ± 0.83 0.013 ± 0.75 2.33 2.33 - -
DXR 0.013 ± 1.03 0.012 ± 0.89 14.25 22.83 - -
DMSO+DXR 0.013 ± 0.75 0.010 ± 0.51 14.08 22.25 - -
A. a. I + DXR 0.012 ± 1.16 0.011 ± 0.81 11.33 9.66 34.72 63.70
A. a. II + DXR 0.013 ± 0.75 0.011 ± 0.83 10.08 9.25 36.80 65.72
A. a. III + DXR 0.012 ± 0.75 0.010 ± 0.51 9.66 9.16 38.19 66.12

Discussion

The present study investigated the genotoxic and antigenotoxic effect of tucumã oil, an Amazonian fruit rich in carotenoids and other bioactive compounds, such as polyphenols.5,12-19 The findings of this study demonstrated that A.a. presents characteristics similar to previously reported results on studies of tucumã, even in its various derivative forms in which it was examined.7,8,19,20

Substances, such as carotenoids and polyphenols found in the oil of tucumã, were previously evaluated by de Rosso and Mercadante,5 and Gonçalves et al.,8 who associated these compounds with the elimination of free radicals. These affirmations are corroborated with this study, because A.a. is described as rich in carotenoids and flavonoids; both compounds are known as antioxidants in the literature.

Several therapeutic properties of bioactive compounds, such as flavonoids, especially quercetin which is abundant in tucumã, have been extensively studied in the last decade, due to their antioxidant effects, anticancer potential, and protective effects on renal, cardiovascular and hepatic systems.19-21, 23

The antimicrobial properties of the tucumã are reported by Jobim et al.21 These antimicrobial effects of the fruit are associated with its chemical composition, which includes several types of polyphenols. According to Daglia,22 polyphenols are secondary metabolites produced by superior plants that have antibacterial, antiviral and antifungal properties.

However, in addition of the variability in bioactive compounds of different natures present in the fruit, the benefits derived from tucumã can be attributed to the antioxidant properties distinct from its several carotenoids. de Rosso and Mercadante5 list 60 species of carotenoids present in different fruits, including 24 in the tucumã.

The bioactive molecules found in the tucumã present great antioxidant capacity.24-26 However, the rich concentration of these molecules in the fixed oil of the fruit is not a guarantee that it will be able to completely reverse the free radicals 19 of a living organism exposed to molecules that can damage the genetic content of the cells.

Chemotherapeutic DXR, used in this study, is an anthracyclic antibiotic and a potent broad spectrum antitumor medicine, often used in the treatment of acute leukemia, lymphomas and tumors.9 Doxorubicin is a micronucleus inducer, and is frequently used in mutagenicity tests as a positive control. It is reported as a metabolically active molecule for a free radical state that interacts with molecular oxygen to generate superoxide radicals.27

The results of the present study demonstrated a significant decrease in the frequency of micronuclei in polychromatic erythrocytes, which corroborates the studies of Sagrillo et al.,19 and de Souza Filho,20 which recognized the protective potential of tucumã in cells submitted to oxidative stress, which is a producer of free radicals. The results obtained in the evaluations of the treatment groups of this study that used A. a. associated with DXR, to test the antigenotoxic effect, indicated a significant reduction of 36.57 ± 1.74% for treatments of 24 hours and 65.18 ± 1, 29% for those of 48 hours.

The results of the genotoxic effect for the three concentrations tested (A. a. I 500 mg, A. a. II 1,000 mg and A. a. III 2,000 mg) as well as the DMSO group, when compared with the negative control group, demonstrated the absence of a toxic effect on DNA. These results corroborate19,20 that different concentrations of tucumã provided a protective effect for the cell to oxidative stress, indicating some carotenoids, such as β-carotene, as an inducer of increased resistance to oxidative DNA damage.20

de Souza Filho et al.,20 in their findings, suggested a relative genotoxic effect of tucumã on human peripheral blood mononuclear cells (PBMC), at concentrations higher than 500 μg/mg, when tested in vitro by the comet assay; however they recognized the methodological limitations related to their study, and emphasized that the results from studies that use only in vitro protocols to analyze the potential genotoxic effect of tucumã cannot be directly transferred to in vivo models.

Sagrillo et al.,19extracted the pulp and peel of tucumã in six different concentrations (100, 300, 600, 900, 1,200, and 1,500 ug/ml) to test its ability to treat oxidative stress induced in human lymphocyte cell cultures, and obtained best results with antioxidants effects at the lowest concentrations tested.

It was verified that there was a significant difference in the reduced rates of micronuclei when comparing treatment times (24 and 48 hours; a 32% difference was found with the 48-hour treatment. Studies that evaluate the genotoxic/antigenotoxic effect of tucumã in vivo were not found to compare results to this research, which makes it the reference for future investigations.

Conclusion

The results of this research demonstrate an evident protective potential for cellular DNA, at all the concentrations used, proving its antigenotoxic potential; however the genotoxic possibility was not demonstrated to be produced by the fixed oil of tucumã in every concentration studied. Therefore, the fixed oil of tucumã is an efficient antigenotoxic agent, producing satisfactory effects as a protector of cellular DNA damage, both at 24 and 48 hours after administration, achieving better results after 48 hours.

Acknowldgements

To the Institute of Scientific and Technological Research (Instituto de Pesquisas Científicas e Tecnológicas) in the State of Amapá, Brazil - IEPA.

REFERENCES

1. Bacelar-Lima CG, Mendonça M, Barbosa T. Morfologia floral de uma população de tucumã Astrocaryum aculeatum G. Mey (Arecaceae) na Amazônia central. Acta Amaz. 2006; 36(4):407-12. [ Links ]

2. Gentil DF, Ferreira SA. Morfologia da plântula em desenvolvimento de Astrocaryum aculeatum Meyer (Arecaceae). Acta Amaz. 2005; 35(3):337-41. [ Links ]

3. Ferreira SA, Castro AF, Gentil DF. Emergência de plântulas de tucumã (Astrocaryum aculeatum) em função do prétratamento das sementes e da condição de semeadura. Rev Bras Frutic. 2010; 32(4):1189-95. [ Links ]

4. Yuyama LK, Maeda RN, Pantoja L, Aguiar JP, Marinho HÁ. Processamento e avaliação da vida-de-prateleira do tucumã (Astrocaryum aculeatum Meyer) desidratado e pulverizado. Ciênc E Tecnol Aliment. 2008; 28(2):408-12. [ Links ]

5. Rosso VV de, Mercadante AZ. Identification and quantification of carotenoids, by HPLC-PDA-MS/MS, from Amazonian fruits. J Agric Food Chem. 2007; 55(13):5062-72. [ Links ]

6. Gross MD, Bishop TD, Belcher JD, Jacobs Jr DR. Induction of HL-60 cell diferentiation by carotenoids. Nutr Cancer. 1997; 27(2):169-73. [ Links ]

7. Ambrósio CL, Campos FA, Faro ZP. Carotenóides como alternativa contra a hipovitaminose A. Rev Nutr. 2006; 19(2):233-43. [ Links ]

8. Gonçalves AE. Avaliação da capacidade antioxidante de frutas e polpas de frutas nativas e determinação dos teores de flavonóides e vitamina C [dissertação]. São Paulo: Universidade de São Paulo; 2008. [ Links ]

9. Injac R, Strukelj B. Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat. 2008; 7(6):497-516. [ Links ]

10. Santos HS dos, Cruz WM. A terapia nutricional com vitaminas antioxidantes e o tratamento quimioterápico oncológico. Rev Bras Cancerol. 2001; 47(3):303-8. [ Links ]

11. Souza RS de, Carvalho SS, Matos DO, Da Silva MH. Novas tecnologias no tratamento quimioterápico por enfermeiros em um hospital. Rev Cient Enferm. 2016; 17(1):24-35. [ Links ]

12. Franke SI, Prá D, Silva J da, Erdtmann B, Henriques JA. Possible repair action of Vitamin C on DNA damage induced by methyl methanesulfonate, cyclophosphamide, FeSO 4 and CuSO 4 in mouse blood cells in vivo. Mutat Res Toxicol Environ Mutagen. 2005; 583(1):75-84. [ Links ]

13. Venkatesh P, Shantala B, Jagetia GC, Rao KK, Baliga MS. Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study. Integr Cancer Ther. 2007; 6(1):42-53. [ Links ]

14. MacGregor, James T., et al. The in vivo erythrocyte micronucleus test: measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam Appl Toxicol. 1990; 14(3):513-22. [ Links ]

15. Brasil. Ministério da Saúde. Manual de diagnóstico laboratorial da malária. Brasília (DF); Ministério da Saúde; 2005. [ Links ]

17. Ribeiro LR, Salvadori DM, Marques EK. Mutagênese ambiental. Canoas: Ed ULBRA; 2003. [ Links ]

18. Waters MD, Brady AL, Stack HF, Brockman HE. Antimutagenicity profiles for some model compounds. Mutat Res Genet Toxicol. 1990; 238(1):57-85. [ Links ]

19. Sagrillo MR, Garcia LF, Souza Filho OC de, Duarte MM, Ribeiro EE, Cadoná FC, et al. Tucuma fruit extracts (Astrocaryum aculeatum Meyer) decrease cytotoxic effects of hydrogen peroxide on human lymphocytes. Food Chem. 2015; 173:741-8. [ Links ]

20. Souza Filho OC de, Sagrillo MR, Garcia LF, Machado AK, Cadoná F, Ribeiro EE, et al. The in vitro genotoxic effect of Tucuma (Astrocaryum aculeatum), an Amazonian fruit rich in carotenoids. J Med Food. 2013; 16(11):1013-21. [ Links ]

21. Jobim ML, Santos RC, Santos Alves CF dos, Oliveira RM, Mostardeiro CP, Sagrillo MR, et al. Antimicrobial activity of Amazon Astrocaryum aculeatum extracts and its association to oxidative metabolism. Microbiol Res. 2014; 169(4):314-23. [ Links ]

22. Daglia M. Polyphenols as antimicrobial agents. Curr Opin Biotechnol. 2012; 23(2):174-181. [ Links ]

23. Böhm F, Edge R, George Truscott T. Interactions of dietary carotenoids with singlet oxygen (1O2) and free radicals: potential effects for human health. Acta Biochim Pol. 2012; 59(1):27-30. [ Links ]

24. Stephensen CB. Provitamin A carotenoids and immune function. In: Sanumihardjo AS. editor. Carotenoids and Human Health. New York: Springer; 2013. Cap. 16. p. 261-70. [ Links ]

25. Skibsted LH. Carotenoids in antioxidant networks. Colorants or radical scavengers. J Agric Food Chem. 2012; 60(10):2409-17. [ Links ]

26. Bianchi ML, Antunes LM. Radicais livres e os principais antioxidantes da dieta. Rev Nutr. 1999; 12(2):123-30. [ Links ]

27. Tavares DC, Cecchi AO, Antunes LM, Takahashi CS. Protective effects of the amino acid glutamine and of ascorbic acid against chromosomal damage induced by doxorubicin in mammalian cells. Teratog Carcinog Mutagen. 1998; 18(4):153-61. [ Links ]

Received: February 15, 2017; Accepted: May 29, 2017

Corresponding author. Alan Bruno Aurélio Carneiro. Rodovia Juscelino Kubitscheck, 68903-419, Macapá, AP, Brazil. abacarneiro@gmail.com

Conflicts of interest: there are no conflicts of interest to declare.

Collaborations

Carneiro ABA, Pinto EJS, Ribeiro IF, Magalhães MRG and Monteiro Neto MAB contributed to the study design, analysis and data interpretation, relevant critical review of the intellectual content, and final approval of the version to be published.

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.